This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Bone Marrow Transplantation Open Access 23 February 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005; 105: 410–419.
Yoshimi A, Bader P, Matthes-Martin S, Stary J, Sedlacek P, Duffner U et al. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005; 19: 971–977.
Bosi A, Laszlo D, Labopin M, Reffeirs J, Michallet M, Gluckman E et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol 2001; 19: 3675–3684.
Manabe A, Okamura J, Yumura-Yagi K, Akiyama Y, Sako M, Uchiyama H et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML working group. Leukemia 2002; 16: 645–649.
Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transpl 2004; 33: 805–814.
Smith FO, King R, Nelson G, Wagner JE, Robertson KA, Sanders JE et al. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br J Haematol 2002; 116: 716–724.
Locatelli F, Niemeyer C, Angelucci E, Bender-Götze C, Burdach S, Ebell W et al. Allogenic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European working group on myelodysplastic syndrome in childhood. J Clin Oncol 1997; 15: 566–573.
Chang YH, Jou ST, Lin DT, Lu MY, Lin KH . Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia: case report and literature review. J Pediatr Hematol Oncol 2004; 26: 190–193.
Acknowledgements
This work was supported by the Deutsche José Carreras Leukämie-Stiftung e.V., München, Germany, and the Alexander von Humboldt-Stiftung, Bonn, Germany. We thank the affected individuals and their families who participated in this study, the physicians who referred the patients, Mrs A Fischer for data management; I Baumann, S Fenu, G Kerndrup and E van Wering for reference review of morphology, B Beverloo, O Haas, J Harbott, K Michalova, L Sainati and B Schlegelberger for reference review of cytogenetic studies.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Yoshimi, A., Mohamed, M., Bierings, M. et al. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia. Leukemia 21, 556–560 (2007). https://doi.org/10.1038/sj.leu.2404537
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404537
This article is cited by
-
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Bone Marrow Transplantation (2023)
-
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)
Pediatric Drugs (2023)
-
Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan
International Journal of Hematology (2015)
-
Successful double umbilical cord blood transplantation for relapsed juvenile myelomonocytic leukemia
Leukemia (2013)